pORF5 plasmid protein of Chlamydia trachomatis induces MAPK-mediated pro-inflammatory cytokines via TLR2 activation in THP-1 cells by Hui Zhou et al.
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2013. This article is published with open access at Springerlink.com life.scichina.com   www.springer.com/scp 
                  
†Contributed equally to this work 
*Corresponding author (email: lzhy1023@hotmail.com) 
• RESEARCH  PAPER • May 2013  Vol.56  No.5: 460–466 
 doi: 10.1007/s11427-013-4470-8 
pORF5 plasmid protein of Chlamydia trachomatis induces 
MAPK-mediated pro-inflammatory cytokines via TLR2 activation 
in THP-1 cells 
ZHOU Hui1,2†, HUANG QiuLin3†, LI ZhongYu1*, WU YiMou1, XIE XiaoBing2, 
MA KangKang1, CAO WenJuan1, ZHOU Zhou1, LU ChunXue1 & ZHONG GuangMing4 
1Pathogenic Biology Institute, University of South China, Hengyang 421001, China; 
2Department of Laboratory Medicine, the First Hospital of Hunan University of Chinese Medicine, Changsha 410007, China; 
3Department of General Surgery, the First Affiliated Hospital of University of South China, Hengyang 421001, China; 
4Department of Microbiology and Immunology, University of Texas Health Science Center, San Antonio, TX 78229, USA 
Received February 27, 2013; accepted March 13, 2013; published online March 27, 2013 
 
Infection with Chlamydia trachomatis induces inflammatory pathologies in the urogenital tract that can lead to infertility and 
ectopic pregnancy. Pathogenesis of infection has been mostly attributed to excessive cytokine production. However, precise 
mechanisms on how C. trachomatis triggers this production, and which protein(s) stimulate inflammatory cytokines remains 
unknown. In the present study, the C. trachomatis pORF5 protein induced tumor necrosis factor alpha (TNF-α), interleukin-1 
beta (IL-1β) and interleukin-8 (IL-8) in dose- and time-dependent manners in the THP-1 human monocyte cell line. We found 
that intracellular p38/mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK)/MAPK sig-
naling pathways were required for the induction of TNF-α, IL-1β and IL-8. Blockade of toll-like receptor 2 (TLR2) signaling 
reduced induction levels of TNF-α, IL-8 and IL-1β. We concluded that the C. trachomatis pORF5 protein might contribute to 
the inflammatory processes associated with chlamydial infections. 
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Chlamydia trachomatis is a pathogenic microorganism re-
sponsible for ocular and sexually transmitted infections. 
Trachoma caused by serovars A, B, Ba and C, is the world’s 
leading cause of infectious blindness [1]. Infections with 
genital serovars D-K mostly manifest as urethritis, prostati-
tis or epididymitis in men, and as cervicitis, salpingitis or 
endometritis in women [2,3]. The L serovars, including L1, 
L2, L2a and L3, often cause disseminated diseases. Chla-
mydial genital tract infection may also significantly increase 
the risk for HIV infection and cervical carcinoma [46]. 
The majority of chlamydial infections are asymptomatic, 
therefore infected individuals often do not receive timely 
medical treatment, and develop a chronic persistent infec-
tion leading to severe complications. Therefore, research on 
chlamydial virulence factors and pathogenic mechanisms is 
required to improve diagnosis and prevention of chlamydial 
infections. 
Infection with C. trachomatis induces a wide array of in-
flammatory cytokines and chemokines [7–9]. These likely 
contribute to chlamydia-induced inflammatory pathologies 
[10]. The pathologies associated with genital infection and 
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ocular trachoma are thought to result from injury during an 
aggressive inflammatory response. However, the precise 
mechanisms related to how chlamydia triggers such a re-
sponse, and which protein(s) stimulate inflammatory cyto-
kines remains unclear. 
Along with a highly conserved genome of around 1000 kb 
of chromosomal DNA, all C. trachomatis serovars also 
contain a 7.5 kb cryptic plasmid [11]. This plasmid encodes 
eight open reading frames, designated pORF1–8. Although 
the function of the plasmid has not been mapped, evidence 
has shown that plasmid-deficient chlamydia fail to induce 
any immune pathology [12]. This would suggest that the 
plasmid might be associated with virulence. As the only 
secreted protein encoded by the plasmid, pORF5 possibly 
contributes to chlamydia-induced pathologies.  
The aims of our study were to determine whether pORF5 
can activate monocytes to produce pro-inflammatory cyto-
kines (TNF-α, IL-1β and IL-8); and determine whether 
TLR2 and MAPKs are required for pORF5-induced cyto-
kine expression by monocyte cells. A recombinant pORF5 
protein was produced and purified, and then human mono-
cyte cells were incubated with pORF5 in the presence or 
absence of anti-TLR antibodies and specific inhibitors of 
MAPKs. We evaluated the effects of pORF5 on IL-1β, IL-8 
and TNF-α production. 
1  Materials and methods  
1.1  Expression and purification of GST-pORF5 fusion 
protein   
A pGEX-6p/pORF5 recombinant plasmid was transformed 
into Escherichia coli XL1-Blue host cells for expression of 
the glutathione S transferase (GST)-pORF5 fusion protein. 
Expression was induced with isopropyl-β-D-thiogalacto- 
pyranoside (IPTG; Invitrogen, Carlsbad, CA), and the fu-
sion protein extracted by lysing E. coli in a lysis buffer (1% 
Triton X-100, 1 mmol L1 phenylmethylsulfonyl fluoride, 
75 U mL1 of aprotinin, 20 μmol L1 leupeptin, and 1.6 
μmol L1 pepstatin) and subjecting to sonication. After 
high-speed centrifugation (12000×g) to remove debris, the 
fusion protein was purified with glutathione-conjugated 
agarose beads (Amersham Pharmacia Biotech, Inc., Pisca-
taway, NJ), and subjected to cleavage of the GST tag with 
PreScission protease (Pharmacia) following the manufac-
turer’s instructions. After concentrating with a Centricon 
YM-10 (Millipore, Billerica, MA) and removing endotoxins 
with polymyxin B (Sigma, St. Louis, MO), the purified 
pORF5 protein was ready to use in macrophage stimulation 
experiments. 
1.2  Cell culture and simulation 
THP-1 cells (TIB-202; ATCC) were cultured in RPMI 1640 
(GIBCO BRL, Rockville, MD) supplemented with 10% 
fetal bovine serum (FBS; GIBCO BRL) at 37°C/5% CO2. 
For stimulation experiments, THP-1 cells were seeded in 
24-well plates at a density of 105 cells mL
1 and cultivated 
in 1% FBS overnight. The purified pORF5 was added to 
cultures as stimuli at the concentrations and times indicated 
for individual experiments. The E. coli lipopolysaccharide 
(LPS; Sigma) was used as a positive control stimulus. In 
some experiments, cells were pretreated with mouse a anti- 
TLR2 antibody (Abcam, Cambridge, UK), PD98059 (Sig-
ma) and SB203580 (Sigma) for 30 min prior to pORF5 
stimulation. 
1.3  ELISA for cytokine detection 
At the end of culture, the cells were lysed by two consecu-
tive cycles of freezing/thawing to yield maximal recovery of 
total cytokines. This included both intracellular cytokines 
and those released into the cell culture. The concentrations 
of TNF-α, IL-1β and IL-8 were measured using human 
ELISA kits (R&D Systems, Inc., Minneapolis, MN), ac-
cording to the manufacturer’s instructions. Briefly, 96-well 
ELISA microplates were coated with a capture antibody, 
and after blocking with 5% BSA, cytokine samples were 
added to the coated plates. This was followed with a biotin- 
conjugated detection antibody. Antibody binding was 
measured with horseradish peroxidase-conjugated avidin 
along with a soluble colorimetric substrate. The absorbance 
was measured at 405 nm using a microplate reader (Molec-
ular Devices Corporation, Sunnyvale, CA) and cytokine 
concentrations calculated.  
1.4  SDS-PAGE and Western blotting   
Cell samples were harvested and solubilized with 2% so-
dium dodecyl sulfate (SDS) sample buffer, then loaded onto 
12% SDS polyacrylamide gels. After electrophoresis, pro-
teins were transferred onto nitrocellulose membranes, and 
incubated with primary antibodies, including rabbit mono-
clonal antibodies against phospho-ERK, phospho-JNK and 
phospho-p38 (Cell Signaling Technology, Beverly, MA), 
and mouse monoclonal antibodies against JNK, p38, and 
ERK (Santa Cruz Biotechnology Inc., Santa Cruz, CA). 
Following incubation with the primary antibody, blots were 
incubated with a secondary antibody conjugated to horse-
radish peroxidase (either goat anti-rabbit or goat anti-mouse 
immunoglobulin G; Jackson Immunologicals, Westgrove, 
PA) and visualized using an enhanced chemiluminescence 
(ECL) kit (Santa Cruz Biotech). 
1.5  Statistical analysis  
Data from three independent experiments are presented as 
the mean±standard deviation. Statistical software (SPSS- 
13.0) was used to analyze results with Student’s t-test fol-
lowed by one-way analysis of variance (ANOVA). A P- 
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value less than 0.05 was considered statistically significant. 
2  Results 
2.1  Expression and purification of pORF5 protein 
The GST-pORF5 fusion protein was expressed in a prokar-
yotic expression system and purified with glutathione aga-
rose beads. The purified GST-pORF5 was cleaved with 
PreScission protease to remove the GST tag. We observed 
the tagged and purified pORF5 (54 kD), along with the 
cleaved pORF5 (28 kD) on SDS-PAGE gels (Figure 1A). 
This result was confirmed by Western blotting analysis us-
ing the specific monoclonal mouse anti-pORF5 antibody 
(clone 2H4) (Figure 1B). 
2.2  pORF5 protein induces inflammatory cytokines in 
THP-1 cells 
The purified pORF5 induced TNF-α, IL-1β and IL-8 pro-
duction in THP-1 cells in a dose-dependent manner, for the 
concentration range 1–8 μg mL1 (Figure 2A). From 1–6  
μg mL1, a correlation between dose and cytokine produc-
tion was observed. Low concentrations of pORF5 induced 
low levels of cytokine secretion, while higher concentra-
tions induced higher levels of cytokine production. When 
the concentration was greater than 6 μg mL1, production of 
TNF-α, IL-1β and IL-8 decreased. Cytokine production was 
also time-dependent from 6–36 h, with TNF-α levels peak-
ing at 6 h post-stimulation. The peak amounts of IL-1β and 
IL-8 occurred at 12 h post-stimulation (Figure 2B). In all 
experiments, E. coli LPS was used as the positive control, 
as this is the most effective stimuli in triggering cytokine 
production. The negative control, phosphate-buffered saline 
(PBS), barely induced any expression of cytokines. 
No endotoxins were detected using a Limulus amebocyte 
lysate assay for the purified pORF5 protein. The possibility 
that its pro-inflammatory activity was attributed to LPS 
contamination was further investigated by testing pORF5 
sensitivity to polymyxin B. As shown in Figure 2C, pORF5 
pre-treated with 50 μg mL1 polymyxin B had no effect on 
TNF-α production (P>0.05) while blocking most of the 
LPS-mediated stimulation activity (P<0.01). 
2.3  pORF5 activates ERK and p38/MAPK signaling 
pathways 
As shown in Figure 3, pORF5 activated p38/MAPK and 
ERK/MAPK pathways, but was unable to activate the 
JNK/MAPK. The p38/MAPK and ERK/MAPK pathways 
were activated at about 15 min after pORF5 stimulation, 
peaking at 15 and 30 min, respectively, then gradually de-
creased. 
2.4  p38/MAPK and ERK/MAPK pathways are in-
volved in pro-inflammatory cytokine production in-
duced by pORF5 protein 
After pretreating with SB202190, a p38/MAPK inhibitor, 
and PD98059, an ERK/MAPK inhibitor, at three different 
doses (1, 10 and 30 μmol L1) for 30 min, THP-1 cells were 
stimulated with 6 μg mL1 pORF5 for 12 h. We then exam-
ined the levels of TNF-α, IL-1β and IL-8 to assess the ef-
fects on the production of different cytokines. As shown in 
Figure 4, inhibition of p38/MAPK and ERK/MAPK path-
ways reduced pORF5-induced TNF-α, IL-1β and IL-8 pro-
duction levels. SB202190 and PD98059 effected pro-   
inflammatory cytokine production in a dose-dependent 
manner. Compared with the control group, the levels of 
TNF-α, IL-1β and IL-8 were reduced to 22.4%, 27.6% and 
22.8% respectively, when 30 μmol L1 SB202190 was used 
(Figure 4A). When 30 μmol L1 PD98059 was used, TNF-α, 
IL-1β and IL-8 levels were reduced by 60.3%, 58.8% and 




Figure 1  Purification and identification of the pORF5 protein. A, Coomassie blue-stained acrylamide gel after SDS-PAGE. Lane 1, marker; 2, 
GST-pORF5; 3, incompletely cleaved GST-pORF5; 4, pORF5 eluate 1; 5, pORF5 eluate 2; 6, pORF5 eluate 3. B, Western blotting assay. Lane 1, XL1-Blue 
E. coli lysate; 2, eluted GST-pORF5 agarose beads after protease cleavage; 3, supernatant of GST-pORF5 agarose beads after cleavage with protease. 
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Figure 2  Induction of inflammatory cytokines by the pORF5 protein. A, Dose-dependent effects of purified pORF5 on the production of TNF-α, IL-1β and 
IL-8 in THP-1 cells. THP-1 cells were incubated for 12 h with or without pORF5 at final concentrations ranging from 2–8 μg mL1. LPS at a final concentra-
tion of 100 ng mL1 was used as a positive control, and PBS was used as a negative control. Samples were collected and assayed for TNF-α, IL-1β and IL-8 
production. Data were obtained from three independent experiments. The error bars indicated standard deviations. B, Time-dependent effects of purified 
pORF5 on TNF-α, IL-1β and IL-8 production in THP-1 cells. THP-1 cells were incubated with 6 μg mL1 pORF5 for 0–36 h. Samples were harvested and 
assayed for TNF-α, IL-1β and IL-8 production. Data are expressed as mean±SD (n=3). Error bars indicate standard deviations. C, Effects of polymyxin B on 
pORF5- and LPS-induced TNF-α production in THP-1 cells. pORF5 or LPS was pre-treated with 50 μg mL1 polymyxin B for 1 h before stimulating THP-1 
cells. pORF5 (6 μg mL1) or LPS (100 ng mL1) were then added to culture medium. After a 12-h incubation, samples were harvested and the concentration 
of TNF-α determined by ELISA. The data were from three independent experiments. Error bars indicate standard deviations.  
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Figure 3  Activation of MAPKs induced by pORF5 in THP-1 cells. 
THP-1 cells were incubated with 6 μg mL1 pORF5 for 0–60 min. Activa-
tion of p38, ERK and JNK was detected by Western blotting using the 
appropriate specific antibodies. 
 
Figure 4  Effects of specific MAPK inhibitors on pORF5-induced cyto-
kine production. THP-1 cells were pre-incubated with three different con-
centrations of SB202190 (A), PD98059 (B) or dimethyl sulfoxide (DMSO) 
for 30 min. We then added 6 μg mL1 pORF5 to the medium. TNF-α, 
IL-1β and IL-8 levels were detected by ELISA. Our results were repre-
sentative of three independent experiments. 
 
Figure 5  TLR2 is involved in the production of TNF-α, IL-1β and IL-8. 
THP-1 cells were pre-incubated with 10 μg mL1 anti-TLR2, or isotype- 
matched mouse IgG for 30 min. Purified pORF5 was added at a final con-
centration of 6.0 μg mL1. TNF-α, IL-1β and IL-8 concentrations were 
determined by ELISA. *, P<0.01 compared with the control groups. 
2.5  TLR2 is involved in pORF5-induced proinflam-
matory cytokine production 
Compared with the control group, blocking TLR2 with a 
neutralizing anti-human TLR2 antibody resulted in signifi- 
cant reduction of pro-inflammatory cytokine production 
induced by pORF5 (P<0.01). The TLR2 antibody had neg-
ligible effect on LPS-inducing cytokine production (data not 
shown). The control IgG did not influence the production of 
IL-1β, IL-8 and TNF-α (Figure 5).  
3  Discussion  
C. trachomatis is an obligate intracellular bacterial pathogen. 
During intravacuolar growth, C. trachomatis must secrete 
factors into the inclusion membrane [13–15] or the host cell 
cytosol [16–18] for interacting with and/or manipulating 
host cell signaling pathways [19–21]. As a result of chla-
mydia-host interactions, host cell genes encoding inflam-
matory cytokines and chemokines are often activated. Pre-
vious studies have been shown that a wide array of inflam-
matory cytokines and chemokines, including IL-1α, IL-6, 
IL-8, IL-18, TNF-α [7–9], are produced in vitro and/or in 
vivo. These are believed to contribute to chlamydia-induced 
pathologies [10].  
There are 19 different serovars among C. trachomatis 
species. Almost all serovars contain the 7.5 kb cryptic 
plasmid [11]. Loss of this plasmid has been associated with 
immunopathology and infectivity [22,23]. Vaginal inocula-
tion of mice with a plasmid-cured derivative of C. muri-
darum reduced bacterial burden almost 10-fold, and there 
was an associated absence of oviduct pathology [12]. Other 
research has also indicated that plasmid­negative strains had 
significantly higher 50% infective dose values relative to a 
wild­type matched isolate [24]. These results indicate that 
this cryptic plasmid might be associated with virulence at-
tributes. Of the eight plasmid-encoded proteins, pORF5 has 
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been shown to be the only protein that is secreted and dis-
tributed in the cytosol of infected cells. The remaining sev-
en proteins localize inside chlamydial inclusions [17]. Since 
Chlamydia restricts its own biosynthetic activity within an 
inclusion, pORF5 might be relevant to chlamydial interac-
tions with host cells. Our findings show that purified 
pORF5 induced TNF-α, IL-1β and IL-8 production in dose- 
and time-dependent manners. The inflammatory reactions 
peaked when the pORF5 concentration was 6 μg mL1. 
Higher concentrations of pORF5 were inhibitory to cyto-
kine production, which may indicate some interference with 
the biological function of the cells. TNF-α peaked at 6 h 
post-stimulation, while IL-1β and IL-8 production occurred 
12 h after stimulation. Our observations clearly show 
pORF5 induces cytokine production, and suggest that 
pORF5 might contribute to chlamydia-induced inflamma-
tory pathologies.  
MAPKs comprise a family of proline-directed serine/ 
threonine kinases. These are important signaling pathways 
for the host immune response. Three major MAPKs, ERK, 
p38 and JNK have been identified in the intracellular net-
work that transduces extracellular signals to an intracellular 
response. Previous studies have demonstrated that MAPKs 
contribute to the production of different cytokines during 
chlamydial infection [25,26]. We hypothesized that MAPKs 
were also involved in the production of TNF-α, IL-1β and 
IL-8 induced by pORF5. This hypothesis was verified by 
our results derived from the phosphorylation detection and 
specific inhibitor studies. The effects of specific inhibitors 
on cytokine production varied. When p38/MAPK was 
blocked 30 μmol L1 SB202190, levels of TNF-α, IL-1β and 
IL-8 were reduced. Blocking ERK/MAPK with 30 μmol L1 
PD98059 further reduced TNF-α, IL-1β and IL-8 levels. 
The p38/MAPK pathway appeared to be more sensitive to 
cytokine responses following pORF5 stimulation. 
TLRs are transmembrane receptors within the IL-1 re-
ceptor superfamily. They are regarded as the major mole-
cules by which hosts recognize invading microorganisms. 
Recent experiments have shown that TLR2 plays a funda-
mental role in chlamydia pathology. TLR2-deficient mice 
did not develop oviduct pathology after infection, demon-
strating that TLR2 signaling is directly involved in disease 
development [27,28]. Data from mouse models have 
demonstrated that plasmid­deficient C. muridarum failed to 
activate TLR2-dependent immune responses in vivo or in 
vitro [29]. These observations suggest that the plasmid reg-
ulates TLR2-dependent signaling and participates in chla-
mydial pathogenesis. We found that an anti-TLR2 antibody 
significantly inhibited inflammatory cytokine production. 
This indicates that TLR2 likely participates in the produc-
tion of inflammatory cytokines induced by pORF5.  
In summary, we have demonstrated that pORF5 induces 
expression of the pro-inflammatory cytokines TNF-α, IL-1β 
and IL-8 in THP-1 cells. The induction of these cytokines 
has subsequent effects upon TLR2, p38/MAPK and ERK/ 
MAPK. However, further research upstream and down-
stream of the MAPK pathways, and the transcription factors 
need to be conducted. Our findings presented herein now 
provide a better understanding of cytokine release and the 
pathogenicity of C. trachomatis at a molecular level.  
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